The interaction behavior of bovine serum albumin (BSA), lysozyme (LYS), myoglobin (MB), and catalase (CAT) with luminol, respectively, was first studied by chemiluminescence (CL) using flow injection (FI) technique based on the fact that the studied proteins can enhance the CL intensity of luminol. A FI-CL model of protein-luminol interaction, , was constructed, and the interaction parameters of BSA, LYS, MB, and CAT with luminol were determined accordingly. The binding constants are in the descending order of CAT > MB > LYS > BSA at the level of 105 to 107？L？mol？1, and the number of binding sites of luminol to BSA or LYS is around 2 and to MB or CAT is around 1. The results of thermodynamic parameters ( , , and ) showed that the binding processes of luminol to the four proteins are spontaneous mainly through the hydrophobic force. 1. Introduction Proteins possess many biological functions including binding, catalysis, operating as molecular switches, and serving as structural components of cells and organisms [1, 2] and play an important role in the transportation and deposition of various endogenous and exogenous substances [3, 4]. In recent years, the interaction of protein with small molecules has become a hot spot in the fields of chemistry, biology, and medicine [5–7]. As common model proteins, bovine serum albumin (BSA) [8], lysozyme (LYS) [9], myoglobin (MB) [10], and catalase (CAT) [11] are widely applied to the study of protein-small molecule interaction. Accordingly, many methods have been utilized to investigate this hot topic, such as fluorescence spectroscopy [12], resonance light scattering [13], circular dichroism [14], nuclear magnetic resonance spectroscopy [15], and chemiluminescence (CL) with flow injection (FI) technique [16]. The FI-CL analysis has proven to be a very useful analytical method with advantages of simple apparatus, high sensitivity, wide dynamic ranges, reproducibility, automatability, less reagent consumption [17–19], and so forth. Luminol (5-amino-2, 3-dihydro-1, 4-phthalazinedione) is known to produce CL with the characteristic wavelength of 425？nm under alkaline condition [20, 21], making it widely used around the world as a blood enhancement technique in forensic science. Also this luminescent compound is used clinically in the treatment of alopecia [22], the promotion of blood clotting [23], and wound healing [24]. Due to its high quantum yield, the CL of luminol has been used in many laboratory applications, including environmental field of analyzing trace metals [25, 26], food safety field [27], biological
References
[1]
K. Teilum, J. G. Olsen, and B. B. Kragelund, “Functional aspects of protein flexibility,” Cellular and Molecular Life Sciences, vol. 66, no. 14, pp. 2231–2247, 2009.
[2]
A. Dhar, K. Girdhar, D. Singh, H. Gelman, S. Ebbinghaus, and M. Gruebele, “Protein stability and folding kinetics in the nucleus and endoplasmic reticulum of Eucaryotic Cells,” Biophysical Journal, vol. 101, no. 2, pp. 421–430, 2011.
[3]
G. Paramaguru, A. Kathiravan, S. Selvaraj, P. Venuvanalingam, and R. Renganathan, “Interaction of anthraquinone dyes with lysozyme: evidences from spectroscopic and docking studies,” Journal of Hazardous Materials, vol. 175, no. 1–3, pp. 985–991, 2010.
[4]
R. J. Pantazes, M. J. Grisewood, and C. D. Maranas, “Recent advances in computational protein design,” Current Opinion in Structural Biology, vol. 21, no. 4, pp. 467–472, 2011.
[5]
H. M. Zhang, J. Chen, Q. H. Zhou, Y. Q. Shi, and Y. Q. Wang, “Study on the interaction between cinnamic acid and lysozyme,” Journal of Molecular Structure, vol. 987, no. 1–3, pp. 7–12, 2011.
[6]
N. Shahabadi and M. Mohammadpour, “Study on the interaction of sodium morin-5-sulfonate with bovine serum albumin by spectroscopic techniques,” Spectrochimica Acta A, vol. 86, pp. 191–195, 2012.
[7]
W. Du, T. Teng, C. C. Zhou, L. Xi, and J. Z. Wang, “Spectroscopic studies on the interaction of bovine serum albumin with ginkgolic acid: binding characteristics and structural analysis,” Journal of Luminescence, vol. 132, no. 5, pp. 1207–1214, 2012.
[8]
G. W. Zhang, N. Zhao, X. Hu, and J. Tian, “Interaction of alpinetin with bovine serum albumin: probing of the mechanism and binding site by spectroscopic methods,” Spectrochimica Acta A, vol. 76, no. 3-4, pp. 410–417, 2010.
[9]
W. P. Wang, W. A. Min, J. R. Chen, X. H. Wu, and Z. D. Hu, “Binding study of diprophylline with lysozyme by spectroscopic methods,” Journal of Luminescence, vol. 131, no. 4, pp. 820–824, 2011.
[10]
D. Ganini, M. Christoff, M. Ehrenshaft, M. B. Kadiiska, R. P. Mason, and E. J. H. Bechara, “Myoglobin-H2O2 catalyzes the oxidation of β-ketoacids to α-dicarbonyls: mechanism and implications in ketosis,” Free Radical Biology and Medicine, vol. 51, no. 3, pp. 733–743, 2011.
[11]
M. I. González-Sánchez, F. García-Carmona, H. Macià, and E. Valero, “Catalase-like activity of human methemoglobin: a kinetic and mechanistic study,” Archives of Biochemistry and Biophysics, vol. 516, no. 1, pp. 10–20, 2011.
[12]
N. S. Moyon and S. Mitra, “Luminol fluorescence quenching in biomimicking environments: sequestration of fluorophore in hydrophobic domain,” Journal of Physical Chemistry B, vol. 115, no. 33, pp. 10163–10172, 2011.
[13]
J. B. Xiao, J. W. Chen, H. Cao, and F. L. Ren, “Study of the interaction between baicalin and bovine serum albumin by multi-spectroscopic method,” Journal of Photochemistry and Photobiology A, vol. 191, no. 2-3, pp. 222–227, 2007.
[14]
T. Banerjee, S. K. Singh, and N. Kishore, “Binding of naproxen and amitriptyline to bovine serum albumin: biophysical aspects,” Journal of Physical Chemistry B, vol. 110, no. 47, pp. 24147–24156, 2006.
[15]
B. L. Cao, S. Endsley, and N. H. Andersen, “19F NMR studies of tryptophan/serum albumin binding,” Bioorganic and Medicinal Chemistry, vol. 11, no. 1, pp. 69–75, 2003.
[16]
Y. M. Huang, Z. Z. Zhang, D. J. Zhang, and J. D. Lv, “Flow-injection analysis chemiluminescence detection combined with microdialysis sampling for studying protein binding of drug,” Talanta, vol. 53, no. 4, pp. 835–841, 2001.
[17]
S. Kulmala and J. Suomi, “Current status of modern analytical luminescence methods,” Analytica Chimica Acta, vol. 500, no. 1-2, pp. 21–69, 2003.
[18]
X. Wang, J. M. Lin, M. L. Liu, and X. L. Cheng, “Flow-based luminescence-sensing methods for environmental water analysis,” Trends in Analytical Chemistry, vol. 28, no. 1, pp. 75–87, 2009.
[19]
M. C. Icardo and J. M. Calatayud, “Photo-induced luminescence,” Critical Reviews in Analytical Chemistry, vol. 38, no. 2, pp. 118–130, 2008.
[20]
E. H. White, O. Zafiriou, H. H. K？gi, and J. H. M. Hill, “Chemiluminescence of luminol: the chemical reaction,” Journal of the American Chemical Society, vol. 86, no. 5, pp. 940–941, 1964.
[21]
J. M. Sanders, L. J. Chen, L. T. Burka, and H. B. Matthews, “Metabolism and disposition of luminol in the rat,” Xenobiotica, vol. 30, no. 3, pp. 263–272, 2000.
[22]
S. Irie, “The treatment of alopecia areata with 3-aminophthal-hydrazide,” Current Therapeutic Research, Clinical and Experimental, vol. 2, no. 3, pp. 107–110, 1960.
[23]
S. Irie, “Influence of 3-aminophthalhydrazide on the prothrombin time,” Current Therapeutic Research, Clinical and Experimental, vol. 2, no. 5, pp. 153–157, 1960.
[24]
S. Irie, “The treatment of wounds with 3-aminophthalhydrazide,” The American surgeon, vol. 27, pp. 642–645, 1961.
[25]
H. Zhang, T. Shibata, T. Krawczyk et al., “Facile detection of proteins on a solid-phase membrane by direct binding of dextran-based luminol-biotin chemiluminescent polymer,” Talanta, vol. 79, no. 3, pp. 700–705, 2009.
[26]
S. Bi, H. Zhou, and S. Zhang, “Multilayers enzyme-coated carbon nanotubes as biolabel for ultrasensitive chemiluminescence immunoassay of cancer biomarker,” Biosensors and Bioelectronics, vol. 24, no. 10, pp. 2961–2966, 2009.
[27]
K. Mervartová, M. Polá？ek, and J. M. Calatayud, “Recent applications of flow-injection and sequential-injection analysis techniques to chemiluminescence determination of pharmaceuticals,” Journal of Pharmaceutical and Biomedical Analysis, vol. 45, no. 3, pp. 367–381, 2007.
[28]
A. R. Bowie, M. G. Sanders, and P. J. Worsfold, “Analytical applications of liquid phase chemiluminescence reactions—a review,” Journal of Bioluminescence and Chemiluminescence, vol. 11, no. 2, pp. 61–90, 1996.
[29]
N. S. Moyon and S. Mitra, “On the interaction of luminol with human serum albumin: nature and thermodynamics of ligand binding,” Chemical Physics Letters, vol. 498, no. 1–3, pp. 178–183, 2010.
[30]
X. J. Tan, Z. H. Song, D. H. Chen, and Z. M. Wang, “Study on the chemiluminescence behavior of bovine serum albumin with luminol and its analytical application,” Spectrochimica Acta A, vol. 79, no. 1, pp. 232–235, 2011.
[31]
D. H. Chen and Z. H. Song, “In vitro monitoring of picogram levels of risperidone in human urine via luminollysozyme flow injection chemiluminescence,” Microchimica Acta, vol. 171, no. 3-4, pp. 437–440, 2010.
[32]
Z. M. Wang, D. H. Chen, X. Gao, and Z. H. Song, “Subpicogram determination of melamine in milk products using a luminol-myoglobin chemiluminescence system,” Journal of Agricultural and Food Chemistry, vol. 57, no. 9, pp. 3464–3469, 2009.
[33]
D. H. Chen, Z. M. Wang, Y. Zhang, X. Y. Xiong, and Z. H. Song, “Study on the interaction behavior of catalase with cephalosporins by chemiluminescence with flow injection analysis,” Analytical Methods, vol. 4, no. 6, pp. 1485–1487, 2012.
[34]
G. Scatchard, “The attraction of proteins for small molecules and ions,” Annals of the New York Academy of Sciences, vol. 51, pp. 660–672, 1949.
[35]
A. A. Spector, J. E. Fletcher, and J. D. Ashbrook, “Analysis of long-chain free fatty acid binding to bovine serum albumin by determination of stepwise equilibrium constants,” Biochemistry, vol. 10, no. 17, pp. 3229–3232, 1971.
[36]
P. D. Ross and S. Subramanian, “Thermodynamics of protein association reactions: forces contributing to stability,” Biochemistry, vol. 20, no. 11, pp. 3096–3102, 1981.
